Publication | Open Access

VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares

Drug TargetMedicineDrug DiscoveryRational Drug DesignTarget PredictionUnbalanced Bi-random WalkBiostatisticsPharmacologyLeast SquaresTarget IdentificationAnti-sars-cov-2 Drug